InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Azitra, Inc.

AZTR Clue Score23
United States Fiscal year ends December CIK 0001701478
$0.13 -1.59% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.13 −90.38% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 16 Jun 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue0.3Operating income−9.5Net income−10.7EPS, diluted−12.74Fiscal year 2023Revenue0.7 +141.5%Operating income−7.5Net income−11.3EPS, diluted−54.98Fiscal year 2024Revenue0.0 −98.9%Operating income−11.0Net income−9.0EPS, diluted−15.70Fiscal year 2025Revenue0.0 −100.0%Operating income−11.0Net income−11.0EPS, diluted−2.25
FY2022FY2023FY2024FY2025
Revenue 0.3 0.7 0.0 0.0
Growth +141.5% −98.9% −100.0%
Operating income −9.5 −7.5 −11.0 −11.0
Net income −10.7 −11.3 −9.0 −11.0
Growth
EPS, diluted −12.74 −54.98 −15.70 −2.25

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2022Operating margin−3,328.7%Net margin−3,760.7%Free cash flow margin−2,951.6%Fiscal year 2023Operating margin−1,086.1%Net margin−1,644.9%Free cash flow margin−1,077.1%Fiscal year 2024Operating margin−146,468.5%Net margin−119,566.6%Free cash flow margin−135,897.5%Fiscal year 2025
FY2022FY2023FY2024FY2025
Operating margin −3,328.7% −1,086.1% −146,468.5% n/a
Net margin −3,760.7% −1,644.9% −119,566.6% n/a
Free cash flow margin −2,951.6% −1,077.1% −135,897.5% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−8.3Capital expenditure−0.0Free cash flow−8.4Fiscal year 2023Operating cash flow−7.4Capital expenditure−0.0Free cash flow−7.4Fiscal year 2024Operating cash flow−10.2Capital expenditure−0.0Free cash flow−10.2Fiscal year 2025Operating cash flow−11.2Capital expenditure−0.0Free cash flow−11.2
FY2022FY2023FY2024FY2025
Operating cash flow −8.3 −7.4 −10.2 −11.2
Capital expenditure −0.0 −0.0 −0.0 −0.0
Free cash flow −8.4 −7.4 −10.2 −11.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash3.5Shareholders’ equity−36.3Fiscal year 2023Cash1.8Shareholders’ equity2.9Fiscal year 2024Cash4.6Shareholders’ equity5.7Fiscal year 2025Cash2.1Shareholders’ equity3.8
FY2022FY2023FY2024FY2025
Cash 3.5 1.8 4.6 2.1
Shareholders’ equity −36.3 2.9 5.7 3.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−3,328.7% −1,086.1% −146,468.5% n/a
−3,760.7% −1,642.3% −119,446.1% n/a
−3,760.7% −1,644.9% −119,566.6% n/a
−2,951.6% −1,077.1% −135,897.5% n/a
Spending
2,147.2% 531.1% 62,978.4% n/a
1,281.6% 655.0% 83,590.2% n/a
11.7% 3.9% 114.3% n/a
Returns
n/a −387.3% −157.4% −288.2%
−149.0% −220.6% −121.9% −218.0%
Balance and payout
135.8% 43.1% 22.6% 24.4%